TY - JOUR
TI - In response to the FDA warning about the use of photomedicine in gynecology
AU - Escribano, J.J.
AU - González-Isaza, P.
AU - Tserotas, K.
AU - Athanasiou, S.
AU - Zerbinati, N.
AU - Leibaschoff, G.
AU - Salvatore, S.
AU - Sánchez-Borrego, R.
JO - Journal of Lasers in Medical Sciences
PY - 2019
VL - 34
TODO - 7
SP - 1509-1511
PB - Springer, London
SN - null
TODO - 10.1007/s10103-019-02744-1
TODO - female;  Food and Drug Administration;  gynecology;  human;  Letter;  low level laser therapy;  medical practice;  menopause;  practice guideline;  priority journal;  radiofrequency;  rejuvenation;  sexual function;  surgical technique;  therapy effect;  urine incontinence;  vagina atrophy;  vagina reconstruction;  vaginal rejuvenation;  drug therapy;  phototherapy;  radiofrequency radiation;  United States, Gynecology;  Humans;  Laser Therapy;  Phototherapy;  Practice Guidelines as Topic;  Radio Waves;  United States;  United States Food and Drug Administration
TODO - To alert patients and health care providers about the use of energy-based devices to perform a vaginal “rejuvenation,” cosmetic vaginal procedures, or nonsurgical vaginal procedures to treat symptoms related to menopause, urinary incontinence, or sexual function, the US Food and Drug Administration (FDA) has issued a warning about the effectiveness and safety of such devices. We agree with the FDA that certain devices (laser, radiofrequency, etc.) have been marketed inappropriately for uses that are outside of their cleared or approved intended uses. We want to position ourselves in the strict training of professionals so that the indications and techniques are used in the best possible way, knowing that, similar to any medical or surgical technique, the side effects can appear in the short and long term, and should be recognized and remedied. © 2019, Springer-Verlag London Ltd., part of Springer Nature.
ER -